Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
11/2010
11/18/2010WO2010131676A1 Process for producing pyripyropene derivative
11/18/2010WO2010131147A1 Cyclobutenedione derivatives
11/18/2010WO2010131054A1 Redox drug derivatives
11/18/2010WO2010130794A1 5-pyridin-3-yl-1,3-dihydro-indol-2-on derivatives and their use as modulators of aldosterone synthase and/or cyp11b1
11/18/2010WO2010130139A1 Ascorbic acid aryl acetate/propionate ester, preparation method and pharmaceutical composition thereof
11/18/2010WO2010130034A1 Inhibitors of human immunodeficiency virus replication
11/18/2010WO2010065586A3 Preparation of capecitabine
11/18/2010WO2010036613A8 Novel cyclic benzimidazole derivatives useful anti-diabetic agents
11/18/2010WO2010033543A3 Substituted benzamides as cannabinoid receptor ligands
11/18/2010US20100292468 Process for making thienopyrimidine compounds
11/18/2010US20100292276 Benzimidazole derivatives useful as trp m8 receptor modulators
11/18/2010US20100292263 Cgrp receptor antagonists with tertiary amide, sulfonamide, carbamite and urea groups
11/18/2010US20100292261 Quorum sensing antagonist, method of preventing a biofilm formation using the quorum sensing antagonist and method of reducing a bacterial contamination using the quorum sensing antagonist
11/18/2010US20100292227 Inhibitors of human immunodeficiency virus replication
11/18/2010US20100292225 Aryl pyridine as aldosterone synthase inhibitors
11/18/2010US20100292207 Substituted indazole derivatives active as kinase inhibitors
11/18/2010US20100292190 Novel tubulin polymerisation inhibitors
11/18/2010US20100292180 Pharmaceutical Compositions Comprising Crystal Forms of 5-Azacytidine
11/18/2010CA2762036A1 Inhibitors of human immunodeficiency virus replication
11/18/2010CA2762022A1 Redox drug derivatives
11/18/2010CA2761858A1 5-pyridin-3-yl-1,3-dihydro-indol-2-on derivatives and their use as modulators of aldosterone synthase and/or cyp11b1
11/18/2010CA2761595A1 Polyketide compound
11/18/2010CA2761258A1 Antiviral compounds
11/18/2010CA2760078A1 Process for producing pyripyropene derivatives
11/17/2010EP2251015A1 Modified nucleosides for the treatment of viral infections and abnormal cellular proliferation
11/17/2010EP2250177A1 Luminescence quenchers and fluorogenic probes for detection of reactive species
11/17/2010EP2250164A2 Angiotensin ii receptor blocker derivatives
11/17/2010EP1797035B1 Cyclopropyl piperidine glycine transporter inhibitors
11/17/2010CN101889009A Inhibitors of c-fms kinase
11/17/2010CN101889004A Inhibitors of protein kinases
11/17/2010CN101888997A Synthesis of quaternary salt compounds
11/16/2010US7834200 Processes and intermediates
11/16/2010US7834054 Hydroxamates as therapeutic agents
11/16/2010US7834049 Integrin expression inhibitor
11/16/2010US7834043 Prevent reproduct of aids virus
11/16/2010US7834033 administering a tumor necrosis factor inhibitor; angiogenesis inhibitor; treating inflammatory, and autoimmune diseases
11/16/2010US7834021 3-aminopyrrolidine derivatives as modulators of chemokine receptors
11/16/2010US7834020 Crystal structure; antidepressants; anxiolytic agents; eating disorders; bipolar disorders; Alzheimer's disease; sleep disorders; psychiatric disorders; sexual dysfunctions; fibromyalgia
11/16/2010US7834011 Heterocyclylalkyl derivatives as novel inhibitors of histone deacetylase
11/16/2010US7834010 gastrointestinal disorders, urinary tract disorders such as hyperactive bladder, and cardiovascular disorders without side effects related to CNS activity; acid moiety makes drug unable to cross the blood-brain barrier; carboxy, phosphonic, sulfonic, or phosphoric acid derivative of piboserod (DDL-6001)
11/16/2010US7834004 N-sulfonyl heterocyclic ring such as piperazine connected via sulfonyl group to another fused heterocyclic ring such as benzothiophene or indoline; peroxisome proliferator-activated receptor (PPAR); obesity, diabetes, hyperinsulinemia, metabolic syndrome X, polycystic ovary syndrome
11/16/2010US7834002 4-amino-5-cyanopyrimidine derivatives
11/16/2010US7833999 histamine H3 receptor modulators; obesity, diabetes and central nervous system diseases such as vigilance and sleep disorders; e.g. (+)-2-(cyclohexylmethyl)-N-[2-(1-methylpyrrolidin-2-yl)ethyl] -1,2,3 ,4-tetrahydroisoquinoline-7-sulfonamide
11/16/2010US7833991 Amine compound and use thereof
11/16/2010CA2455621C Use of (r/s)-(-/+) or (s)-(+)-2-[5-(4-fluorophenyl)-3-pyridylmethylaminomethyl]chromane for the treatment of extrapyramidal movement disorders
11/16/2010CA2409613C Methods and compositions for treating hepatitis c virus
11/11/2010WO2010129451A1 Process for preparing bromo-substituted quinolines
11/11/2010WO2010129379A1 Inhibitors of the renal outer medullary potassium channel
11/11/2010WO2010129211A2 Preparation of decitabine
11/11/2010WO2010128995A1 Phenoxymethyl heterocyclic compounds
11/11/2010WO2010128659A1 Diamino heterocyclic carboxamide compound
11/11/2010WO2010127855A1 Substituted aromatic carboxamide and urea derivatives as vanilloid receptor ligands
11/11/2010WO2010105179A3 Inhibitors of beta-secretase
11/11/2010WO2010096371A3 Heterocyclic compounds which modulate the cb2 receptor
11/11/2010WO2010054138A3 Modulators of atp-binding cassette transporters
11/11/2010WO2009016498A8 Pyrimidine and pyridine derivatives and their pharmaceutical use and compositions
11/11/2010WO2007143597A9 Organic compounds
11/11/2010US20100286219 1, 3-Dihydroimidazoles for Treating Cardiovascular Disorders
11/11/2010US20100286212 Treating and Preventing Viral Infections
11/11/2010US20100286152 N-phenyl hydrazides as modulators of the ghrelin receptor
11/11/2010US20100286135 Heterocyclic amide compounds as protein kinase inhibitors
11/11/2010US20100286123 Inhibitors of the renal outer medullary potassium channel
11/11/2010US20100286118 Substituted 1-cyanoethylheterocyclylcarboxamide compounds 750
11/11/2010US20100286110 Azetidinyl g-protein coupled receptor agonists
11/11/2010US20100285957 Thiazolyloxyphenylamidines or thiadiazolyloxyphenylamidines and their use as fungicides
11/11/2010CA2764232A1 Novel heterocyclic compounds
11/11/2010CA2761032A1 Phenoxymethyl heterocyclic compounds
11/11/2010CA2760061A1 Diamino heterocyclic carboxamide compound
11/11/2010CA2759399A1 Inhibitors of the renal outer medullary potassium channel
11/11/2010CA2758302A1 Compounds and compositions comprising cdk inhibitors and methods for treatment of cancer
11/11/2010CA2758289A1 Substituted aromatic carboxamide and urea derivatives as vanilloid receptor ligands
11/10/2010EP2248811A1 2-oxochromene derivative
11/10/2010EP2248806A2 Quinazoline derivatives as tyrosine kinase inhibitors
11/10/2010EP2248423A1 Composition for agricultural use for controlling or preventing plant diseases caused by plant pathogens
11/10/2010EP2247586A1 2-aza-bicyclo[2.2.1]heptane derivatives
11/10/2010EP2247580A1 Quinoxalinone derivatives as insulin secretion stimulators, methods for obtaining them and use thereof for the treatment of diabetes
11/10/2010EP2247575A2 Cyclic indole-3-carboxamides, their preparation and their use as pharmaceuticals
11/10/2010EP1653944B1 Heterocyclic compounds useful as malonyl-coa decarboxylase inhibitors
11/10/2010CN1984900B Indole derivatives having piperidine rings
11/10/2010CN101880277A Aza spiro alkane derivatives as inhibitors of metallproteases
11/10/2010CN101171249B Method for producing indole derivative having piperidine ring
11/09/2010US7829729 epoxidation reaction of 3,3-dinitroazetidine with epichlorohydrin; as energetic binder with enhanced thermal and storing stability, and explosive power
11/09/2010US7829728 2-[(S)-1-(9-{Benzyl-1,2-(8-benzyloxy-2-oxo-1,2-dihydroquinolin-5-yl)-2-oxoethyl]-amino}nonyl)pyrrolidin-3-yl -2,2-diphenylacetamide; beta 2 adrenergic receptor agonist, muscarinic receptor antagonist activity; chronic obstructive pulmonary disease and asthma
11/09/2010US7829713 Therapeutic piperazines
11/09/2010US7829597 preventing the formation of insoluble A beta and arresting the production of A beta; beta-site amyloid precursor protein-cleaving enzyme; 3-[(2-amino-2-methyl-3-phenylpropoxy)methyl]-N-[(1R)-1-(4-fluorophenyl)ethyl]-[methyl(methylsulfonyl)amino]benzamide
11/09/2010US7829585 such as 2-Amino-N-(5-ethoxymethyl-benzofuran-2-ylmethyl)-6-methoxymethyl-nicotinamide, used for treating a fungal infections; superior physical properties, safety and metabolic stability
11/09/2010US7829583 Biphenyl derivatives
11/09/2010US7829580 Cyclic amine derivative having heteroaryl ring
11/09/2010US7829571 monocyte chemotactic protein antagonists such as -(3S)-1-(4-(tert-butylamino)cyclohexyl)-3-(6-(trifluoromethyl)quinazolin-4-ylamino)pyrrolidin-2-one, used for the treatment of asthma, multiple sclerosis, arteriosclerosis and rheumatoid arthritis
11/09/2010US7829565 such as 5-{4-[4-(5-cyano-2,3-dihydro-1H-indol-3-yl)butyl]piperazin-1-yl}benzo-furan-2-carboxamide, used as antidepressant, anxiolytic, neuroleptic and/or hyportensive agents and for treating headaches, tardive dyskinesia, obsessive compulsive, sleep, eating, sexual and/or learning disorders
11/09/2010US7829564 α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
11/09/2010CA2547283C Aminopyrazole derivatives as gsk-3 inhibitors
11/09/2010CA2496164C Benzimidazole quinolinones and uses thereof
11/09/2010CA2484188C Tachykinin receptor antagonists
11/09/2010CA2453623C 6-aryl-4-aminopicolinates and their use as herbicides
11/09/2010CA2380070C New derivatives of hydantoines, thiohydantoine, pyrimidinediones and thioxopyrimidinones, their preparation methods and their application as medications
11/04/2010WO2010127307A1 Antimicrobial agents
11/04/2010WO2010126014A1 Novel solvate crystals
11/04/2010WO2010126013A1 Method for producing olmesartan medoxomil
11/04/2010WO2010125831A1 Sulfamoyl benzoic acid derivatives as trpm8 antagonists
1 ... 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 ... 694